The alleged violations occurred before Pfizer bought Biohaven and its migraine treatment three years ago for $11.6 billion.
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback